Absorption |
Blood-Brain Barrier | BBB- | 0.9704 |
Human Intestinal Absorption | HIA- | 0.7776 |
Caco-2 Permeability | Caco2- | 0.7432 |
P-glycoprotein Substrate | Substrate | 0.6934 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.8863 |
Non-inhibitor | 0.8724 |
Renal Organic Cation Transporter | Non-inhibitor | 0.8301 |
Distribution |
Subcellular localization | Mitochondria | 0.3610 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.9002 |
CYP450 2D6 Substrate | Non-substrate | 0.8161 |
CYP450 3A4 Substrate | Non-substrate | 0.5000 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.9045 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.9070 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9231 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.9026 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.8309 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9029 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9897 |
Non-inhibitor | 0.8950 |
AMES Toxicity | Non AMES toxic | 0.7495 |
Carcinogens | Non-carcinogens | 0.8549 |
Fish Toxicity | High FHMT | 0.9724 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9239 |
Honey Bee Toxicity | Low HBT | 0.6562 |
Biodegradation | Not ready biodegradable | 0.9911 |
Acute Oral Toxicity | IV | 0.6139 |
Carcinogenicity (Three-class) | Non-required | 0.4662 |